Viewpoints

Latest

14 May 2020

COVID-19 and antimicrobial resistance: Are there any unknowns that will become known?

COVID-19 represents an unprecedented public health crisis that will bring many novel insights. This worldwide disturbance will probably affect the epidemiology of antimicrobial resistance (AMR) in many different ways that we have not previously considered.

The critical need for alternative approaches to address antibiotic treatment failure

COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever

The antibiotics marketplace collapse: It’s just math and it’s a solvable equation

Diagnostics to safeguard new and current antibiotics for gonorrhoea

On fireworks and finding ways to address drug resistance in low- and middle-income countries

Bringing antimicrobial research and development to Africa: The time is now

Cookie Policy

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.